InvestorsHub Logo
icon url

jimmieh

02/08/07 9:02 AM

#28 RE: vincent333 #26

Fantastic News! Ultimately, the only way AXMP (or any other company, for that matter)is going to survive is to begin generating revenue. It doesn't have to be thismonth or year, but it must be on track to do so...

This distribution agreement and the other recent developments have made me "upgrade" the company's health from critical to stable.

Let's hope that in the coming weeks-- and months -- there will be similar good news!

Jimmie
icon url

checkmate28

02/08/07 9:32 AM

#30 RE: vincent333 #26

Congrats to the longs. I added recently. I believed they would get through the fraud. I also noticed that there was no signifigant delution as there really had been no volume.

A few thoughts on the following:

AXM Pharma Inc. a manufacturer of proprietary and generic pharmaceutical and nutraceutical products for the Chinese and other Asian markets, announced today that Brazil Wahsun Import & Export Ltd. has signed a ten-year agreement, under which AXM Pharma has been designated exclusive distributor for Sygen, a product which is produced by TRB Pharma of Brazil. Sygen measures pathological changes in the central nervous system and Parkinson's disease. AXM has entered into agreements with distributors from leading cities and provinces of Shanghai, Beijing, Guangdong, Jiangsu, Zhejiang and Shandong, to purchase a total quantity of 500,000 units, resulting in 2007 estimated revenue of $12,820,000

The fact that they are master distributor Brazil Wahsun and have entered into multiple agreements with other distributors, leads me to believe they have a nice distribution network set up to move other products they either are currently manufacturing or are intending to manufacture from their new plant.
It also seems that they have been busy with business while they were taking care of the SEC mishap. Now that thats behind, maybe we will see a stream of PR's having to do with moving forward.

I'm excited!!!
GLTA Checkmate28